AMDL, a specialty pharmaceuticals company, has announced the launch of new products for its Goodnak anti-aging line.
Subscribe to our email newsletter
The company is releasing the new Goodnak formulations in partnership with JJB, the subsidiary of AMDL’s Chinese subsidiary Jade Pharmaceutical. Scheduled to be released in June, 2008, the Goodnak product includes human placental histosolution, and effective and key component in anti-aging products which has been shown to give skin a youthful look by increasing cell renewal and smoothening fine lines.
JJB has applied to Chinese regulatory authorities for product approval and anticipates sanction this month.
Frank Zhang, managing Director of Jade Pharmaceutical, said: “The new Goodnak consumer products are expected to be highly popular and anticipated sales growth is expected to significantly increase in 2008 and beyond. This product may also be extremely an exceptionally good candidate for export to the North American and European beauty care markets.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.